Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naive men with oligometastatic prostate cancer to bone.

被引：0
|
作者：
Tward, Jonathan David
Johnson, Skyler B.
Kokeny, Kristine E.
Lloyd, Shane
Cannon, Donald Maurice
Dechet, Christopher B.
ONeil, Brock
Stephenson, Robert
Boucher, Kenneth M.
Gupta, Sumati
Swami, Umang
Maughan, Benjamin L.
Agarwal, Neeraj
机构：
[1] Univ Utah, Hunstman Canc Inst, Salt Lake City, UT USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[3] Huntsman Canc Hosp, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
156
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mature results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic prostate cancer to bone.
    Tward, Jonathan David
    Johnson, Skyler B.
    Kokeny, Kristine E.
    Lloyd, Shane
    Cannon, Donald Maurice
    Dechet, Christopher B.
    ONeil, Brock
    Stephenson, Robert A.
    Boucher, Kenneth M.
    Kohli, Manish
    Gupta, Sumati
    Swami, Umang
    Maughan, Benjamin L.
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 160 - 160
  • [2] Radium-223 for men with hormone-refractory prostate cancer and bone metastases
    Shelley, Mike D.
    Mason, Malcolm D.
    LANCET ONCOLOGY, 2007, 8 (07): : 564 - 565
  • [3] Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer
    Armstrong, Andrew J.
    Gupta, Santosh
    Healy, Patrick
    Kemeny, Gabor
    Leith, Beth
    Zalutsky, Michael R.
    Spritzer, Charles
    Davies, Catrin
    Rothwell, Colin
    Ware, Kathryn
    Somarelli, Jason A.
    Wood, Kris
    Ribar, Thomas
    Giannakakou, Paraskevi
    Zhang, Jiaren
    Gerber, Drew
    Anand, Monika
    Foo, Wen-Chi
    Halabi, Susan
    Gregory, Simon G.
    George, Daniel J.
    PLOS ONE, 2019, 14 (05):
  • [4] Phase I pharmacokinetic (PK) and biodistribution study of radium-223 chloride in patients with castration resistant prostate cancer (CRPC) metastatic to bone.
    Carrasquillo, J. A.
    O'Donoghue, J. A.
    Pandit-Taskar, N.
    Rathkopf, D. E.
    Aksnes, A.
    Viner, C. L.
    Hong, C. T.
    Larson, S. M.
    Scher, H. I.
    Morris, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] A phase 1/2 study of olaparib and radium-223 in men with metastatic castration-resistant prostate cancer (mCRPC) with bone metastases (COMRADE): Results of the phase 1 study.
    McKay, Rana R.
    Xie, Wanling
    Ajmera, Archana
    Saraiya, Biren
    Parikh, Mamta
    Folefac, Edmund
    Olson, Adam C.
    Choudhury, Atish Dipankar
    Einstein, David Johnson
    Heath, Elisabeth I.
    Parikh, Rahul Atul
    Kunos, Charles
    Ivy, S. Percy
    Shapiro, Geoffrey
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancer
    Tombal, Bertrand
    Borre, Michael
    Rathenborg, Per
    Werbrouck, Patrick
    Heidenreich, Axel
    Iversen, Peter
    Baskin-Bey, Edwina S.
    Perabo, Frank
    Phung, De
    Smith, Matthew Raymond
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [7] A Phase lb Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer
    Fong, Lawrence
    Morris, Michael J.
    Sartor, Oliver
    Higano, Celestia S.
    Pagliaro, Lance
    Alva, Ajjai
    Appleman, Leonard J.
    Tan, Winston
    Vaishampayan, Ulka
    Porcu, Raphaelle
    Tayama, Darren
    Kadel, Edward E., III
    Yuen, Kobe C.
    Datye, Asim
    Armstrong, Andrew J.
    Petrylak, Daniel P.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4746 - 4756
  • [8] Updated biomarker results from a phase 1/2 study of olaparib and radium-223 in men with metastatic castration-resistant prostate cancer (mCRPC) with bone metastases (COMRADE).
    Mckay, Rana R.
    Xie, Wanling
    Ajmera, Archana
    Saraiya, Biren
    Parikh, Mamta
    Folefac, Edmund
    Olson, Adam C.
    Heath, Elisabeth I.
    Parikh, Rahul Atul
    Ivy, S. Percy
    Mendel, Eliezer
    Allen, Van
    Lindeman, Neal Ian
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [9] A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)
    Pan, Elizabeth
    Xie, Wanling
    Ajmera, Archana
    Araneta, Arlene
    Jamieson, Christina
    Folefac, Edmund
    Hussain, Arif
    Kyriakopoulos, Christos E.
    Olson, Adam
    Parikh, Mamta
    Parikh, Rahul
    Saraiya, Biren
    Ivy, S. Percy
    Allen, Eliezer M. Van
    Lindeman, Neal I.
    Kochupurakkal, Bose S.
    Shapiro, Geoffrey I.
    McKay, Rana R.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (04) : 511 - 518
  • [10] A phase 1/2 study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress
    Jani, Chinmay
    Xie, Wanling
    Ajmera, Archana
    Araneta, Arlene
    Jamieson, Christina
    Folefac, Edmund
    Hussain, Arif
    Kyriakopoulos, Christos
    Olson, Adam C.
    Parikh, Mamta
    Parikh, Rahul Atul
    Saraiya, Biren
    Jabbour, Salma K.
    Ivy, S. Percy
    Van Allen, Eliezer Mendel
    Lindeman, Neal Ian
    Kochupurakkal, Bose
    Shapiro, Geoffrey
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345